{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T01:13:29Z","timestamp":1775610809337,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T00:00:00Z","timestamp":1725753600000},"content-version":"am","delay-in-days":282,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.anl.2023.04.006","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T15:27:04Z","timestamp":1683559624000},"page":"952-959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comprehensive Genome profile testing in head and neck cancer"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3199-009X","authenticated-orcid":false,"given":"Masashi","family":"Kuroki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Iinuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8374-3798","authenticated-orcid":false,"given":"Hiroshi","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0033-652X","authenticated-orcid":false,"given":"Kosuke","family":"Terazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7104-9456","authenticated-orcid":false,"given":"Hirofumi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimitsu","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitaka","family":"Makiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Futamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiko","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1556-7328","authenticated-orcid":false,"given":"Takenori","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2023.04.006_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.anl.2023.04.006_bib0002","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","author":"Lawrence","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.anl.2023.04.006_bib0003","doi-asserted-by":"crossref","first-page":"E287","DOI":"10.1002\/lary.27130","article-title":"Prognostic factors for human papillomavirus\u2013positive and negative oropharyngeal carcinomas","volume":"128","author":"Yin","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2023.04.006_bib0004","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1158\/1078-0432.CCR-07-1402","article-title":"Inverse relationship between human Papillomavirus-16 infection and disruptive P53 gene mutations in squamous cell carcinoma of the head and neck","volume":"14","author":"Westra","year":"2008","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.anl.2023.04.006_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10051082","article-title":"The genomic landscape of thyroid cancer tumourigenesis and implications for immunotherapy","volume":"10","author":"Singh","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.anl.2023.04.006_bib0006","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc3431","article-title":"Molecular pathogenesis and mechanisms of thyroid cancer","volume":"13","author":"Xing","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.anl.2023.04.006_bib0007","first-page":"164","volume":"9","author":"El-Naggar","year":"2017"},{"key":"10.1016\/j.anl.2023.04.006_bib0008","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.3390\/ijms22136771","article-title":"2021 update on diagnostic markers and translocation in salivary gland tumors","volume":"22","author":"Meyer","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anl.2023.04.006_bib0009","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/PAS.0b013e3181de3021","article-title":"A reappraisal of the MECT1\/MAML2 translocation in salivary mucoepidermoid carcinomas","volume":"34","author":"Seethala","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anl.2023.04.006_bib0010","doi-asserted-by":"crossref","first-page":"66239","DOI":"10.18632\/oncotarget.11288","article-title":"Adenoid cystic carcinoma: emerging role of translocations and gene fusions","volume":"7","author":"Wysocki","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.anl.2023.04.006_bib0011","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","article-title":"Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity","volume":"34","author":"Sk\u00e1lov\u00e1","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anl.2023.04.006_bib0012","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1634\/theoncologist.2019-0841","article-title":"The benefits of adjuvant trastuzumab for HER-2-Positive salivary gland cancers","volume":"25","author":"Hanna","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.anl.2023.04.006_bib0013","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nbt.2696","article-title":"Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing","volume":"31","author":"Frampton","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.anl.2023.04.006_bib0014","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jnci\/djv332","article-title":"Prospective clinical study of precision oncology in solid tumors","volume":"108","author":"Sohal","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.anl.2023.04.006_bib0015","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.3390\/cancers13133312","article-title":"Clinically advanced pheochromocytomas and paragangliomas: a comprehensive genomic profiling study","volume":"13","author":"Bratslavsky","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anl.2023.04.006_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"key":"10.1016\/j.anl.2023.04.006_bib0017","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jmoldx.2019.06.011","article-title":"A novel next-generation sequencing approach to detecting microsatellite instability and pan-tumor characterization of 1000 microsatellite instability\u2013high cases in 67,000 patient samples","volume":"21","author":"Trabucco","year":"2019","journal-title":"J Mol Diagnostics"},{"key":"10.1016\/j.anl.2023.04.006_bib0018","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1200\/JCO.19.03010","article-title":"Molecular landscape and actionable alterations in a genomically guided cancer clinical trial: national cancer institute molecular analysis for therapy choice (NCI-MATCH)","volume":"38","author":"Flaherty","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2023.04.006_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0266112","article-title":"Clinical utility of comprehensive genomic profiling in japan: result of PROFILE-F study","volume":"17","author":"Aoyagi","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.anl.2023.04.006_bib0020","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/cas.13969","article-title":"Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: a hospital-based study","volume":"110","author":"Sunami","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.anl.2023.04.006_bib0021","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1002\/onco.13639","article-title":"Clinical application of the foundation one CDx assay to therapeutic decision-making for patients with advanced solid tumors","volume":"26","author":"Takeda","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.anl.2023.04.006_bib0022","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","article-title":"Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the Multicohort, Open-Label, Phase 2 KEYNOTE-158 study","volume":"21","author":"Marabelle","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.anl.2023.04.006_bib0023","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1158\/1078-0432.CCR-21-3025","article-title":"Afatinib and pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma (ALPHA Study): a phase II study with biomarker analysis","volume":"28","author":"Kao","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anl.2023.04.006_bib0024","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2023.04.006_bib0025","article-title":"Precision oncology and the universal health coverage system in Japan","volume":"3","author":"Ebi","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.anl.2023.04.006_bib0026","article-title":"Biomarkers predictive of response to pembrolizumab in head and neck cancer","author":"Pfister","year":"2022","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.anl.2023.04.006_bib0027","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.3390\/biomedicines10112732","article-title":"Genomic and immune approach in platinum refractory HPV-negative head and neck squamous cell carcinoma patients treated with immunotherapy: a novel combined profile","volume":"10","author":"Mezi","year":"2022","journal-title":"Biomedicines"},{"issue":"14","key":"10.1016\/j.anl.2023.04.006_bib0028","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.3390\/cancers14143476","article-title":"Comprehensive genomic profiling reveals clinical associations in response to immune therapy in head and neck cancer","volume":"14","author":"Noji","year":"2022","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.anl.2023.04.006_bib0029","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1158\/1078-0432.CCR-21-4554","article-title":"Phase II trial of adjuvant nivolumab following salvage resection in patients with recurrent squamous cell carcinoma of the head and neck","volume":"28","author":"Leddon","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anl.2023.04.006_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.756506","article-title":"Combination of tumor mutational burden and specific gene mutations stratifies outcome to immunotherapy across recurrent and metastatic head and neck squamous cell carcinoma","volume":"12","author":"Peng","year":"2021","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.anl.2023.04.006_bib0031","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13000-021-01147-7","article-title":"Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma","volume":"16","author":"Xu","year":"2021","journal-title":"Diagn Pathol"},{"issue":"4","key":"10.1016\/j.anl.2023.04.006_bib0032","doi-asserted-by":"crossref","first-page":"e98811","DOI":"10.1172\/jci.insight.98811","article-title":"Frameshift events predict anti-PD-1\/L1 response in head and neck cancer","volume":"3","author":"Hanna","year":"2018","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.anl.2023.04.006_bib0033","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.annonc.2021.02.006","article-title":"High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types","volume":"32","author":"McGrail","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anl.2023.04.006_bib0034","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1158\/1078-0432.CCR-21-4316","article-title":"Association of TP53 and CDKN2A mutation profile with tumor mutation burden in head and neck cancer","volume":"28","author":"Deneka","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anl.2023.04.006_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.798424","article-title":"Analysis of immunological characteristics and genomic alterations in HPV-positive oropharyngeal squamous cell carcinoma based on PD-L1 expression","volume":"12","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anl.2023.04.006_bib0036","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1038\/s41598-019-49771-0","article-title":"HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma","volume":"9","author":"Wang","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.anl.2023.04.006_bib0037","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ymgme.2008.07.009","article-title":"Case report of familial carney complex due to novel frameshift mutation c.597del C (p.Phe200LeufsX6) in PRKAR1A","volume":"95","author":"Sasaki","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.anl.2023.04.006_bib0038","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.1002\/hed.24634","article-title":"Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-Amplified salivary gland cancer and a review of the literature","volume":"39","author":"Thorpe","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2023.04.006_bib0039","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/17843286.2016.1173940","article-title":"Metastatic HER-2-positive salivary gland carcinoma treated with trastuzumab and a taxane: a series of six patients","volume":"71","author":"De Block","year":"2016","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.anl.2023.04.006_bib0040","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/hed.23940","article-title":"Clinical activity of androgen deprivation therapy in patients with metastatic\/relapsed androgen receptor-positive salivary gland cancers","volume":"38","author":"Locati","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2023.04.006_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.00701","article-title":"First line androgen deprivation therapy vs. chemotherapy for patients with androgen receptor positive recurrent or metastatic salivary gland carcinoma-a retrospective study","volume":"9","author":"Viscuse","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.anl.2023.04.006_bib0042","first-page":"1","article-title":"Genomic context of NTRK1\/2\/3 fusion-positive tumours from a large real-world population","volume":"5","author":"Westphalen","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.anl.2023.04.006_bib0043","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","article-title":"Entrectinib in patients with advanced or metastatic NTRK Fusionpositive solid tumours: integrated analysis of three phase 1\u20132 trials","volume":"21","author":"Doebele","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.anl.2023.04.006_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12920-022-01155-6","article-title":"Clinicopathological Investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report","volume":"15","author":"Suzuki","year":"2022","journal-title":"BMC Med Genomics"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814623000913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814623000913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:40:57Z","timestamp":1759952457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814623000913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0385814623000913"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2023.04.006","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive Genome profile testing in head and neck cancer","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2023.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}